Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of combining thalidomide with glutamine for radiation enteritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)
  • Thalidomide (thalidomide)

Snippet

Sponsor: Yongquan Shi | Conditions: Radiation Enteritis | Phase 2 | Status: RECRUITING